dacarbazine and Lung Adenocarcinoma

dacarbazine has been researched along with Lung Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belinsky, SA; Bernauer, AM; Burki, EA; Costello, JF; Crowell, RE; Do, KC; Flores, KG; Gilliland, FD; Hong, C; Leng, S; Picchi, MA; Prados, MD; Stidley, CA; Tellez, CS; Tessema, M; Willink, RP; Yingling, CM1

Other Studies

1 other study(ies) available for dacarbazine and Lung Adenocarcinoma

ArticleYear
The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Apr-01, Volume: 17, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Antineoplastic Agents, Alkylating; beta-Galactosidase; Cell Line, Tumor; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Genetic Association Studies; Haplotypes; Humans; Linkage Disequilibrium; Luciferases; Lung Neoplasms; Male; Methylation; Middle Aged; Polymorphism, Single Nucleotide; Precancerous Conditions; Promoter Regions, Genetic; Smoking; Sputum; Temozolomide; Transcription, Genetic; Tumor Suppressor Proteins

2011